Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.

2023
https://researcherprofiles.org/profile/432738386
37607392
Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, Raymond R, Ramos EL